Cartman M.L.Lung cancer:district active treatment rates affect survival.Scagliotti, G . V . Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapynaive patients with advanced-stage non-small-cell lung cancer .L . ......